We are building a stronger Business Community in Flemingsberg

We are actively collaborating with key stakeholders to strengthen the innovation ecosystem and promote entrepreneurship in Flemingsberg. A central part of our efforts involves being present alongside other important actors and creating meeting spaces to build close relationships with those who work in the area on a daily basis. We believe that exciting and new opportunities emerge when people come together and exchange ideas.

As part of our Business Community, we recently had the pleasure of inviting Business Sweden to present their latest report, “THE ROAD TO PERSONALISED MEDICINE.” The report highlights the transition to digital health and precision medicine across various markets and emphasizes the business opportunities this development could offer Swedish healthcare companies in Europe. See the interview below with Louise Bengtsson, Senior Consultant at Business Sweden.

Stay updated and sign up for upcoming community events here.

Stockholm region’s only GameTech hub is being built in Flemingsberg

In September this year, Press Start took the next step in developing the Stockholm region’s GameTech ecosystem. Since then, the community has continued to grow, more studios have joined, and work on the next major initiative has gained momentum. So, what has happened so far, and what comes next?

CSIB: New interdisciplinary center brings research together to tackle future infectious threats

Center for Systems Infection Biology (CSIB) was recently inaugurated at Campus Flemingsberg. The new interdisciplinary initiative brings together research, advanced infrastructure and expertise to deepen the understanding of infectious diseases and accelerate the path from research to clinical application. We met with Director Ujjwal Neogi and Co-director Iva Filipovic to talk about the center’s goals, its strong focus on collaboration, and its ambition to contribute to pandemic preparedness.

Vecura – 30 Years Dedicated to the Medicine of the Future

In Flemingsberg, pioneers have helped shape the medicine of the future since 1996. This year, the manufacturing unit Vecura celebrates 30 years of supporting the development of cell and gene therapies – advanced therapies that enable more personalized treatments. We spoke with Pontus Blomberg, strategic advisor and former Director of Operations, who has helped build one of Sweden’s leading laboratories in the field.

Go to Top